Earnings call transcript: Stem Inc Q2 2025 sees 13% revenue rise, stock surges

Stem Inc. reported robust Q2 2025 results, with revenue up 13% year-over-year to $38.4 million and a record 49% non-GAAP gross margin, driving Adjusted EBITDA to $4 million. The company's stock surged 6.87% post-announcement, reflecting investor confidence in its strategic pivot to a software-centric model and significant cost reductions, including a 35% cut in personnel expenses. Crucially, Stem completed a strategic debt exchange, reducing its debt by $195 million and extending maturities, substantially strengthening its balance sheet despite negative Q2 operating cash flow, as management reaffirmed full-year guidance and anticipates positive cash from operations in H2 2025.

Analysis

Stem Inc. reported a strong Q2 2025, demonstrating significant progress in its strategic pivot towards a software-centric, higher-margin business model. Total revenue grew 13% year-over-year to $38.4 million, but more critically, the company achieved a record 49% non-GAAP gross margin and positive adjusted EBITDA of $4 million, a $15 million improvement from the prior year. This margin expansion and return to positive EBITDA were driven by a 22% YoY increase in Annual Recurring Revenue (ARR) to $59 million and aggressive cost management, including a 35% reduction in personnel costs. A pivotal event this quarter was the completion of a strategic debt exchange, which retired approximately $195 million of debt at a discount and extended maturities, substantially strengthening the balance sheet and mitigating near-term financial risk. Despite these positives, the company reported negative operating cash flow of $21 million, attributed to working capital timing and one-time restructuring payments, and maintains a tight current ratio of 0.92. Management reaffirmed its full-year 2025 guidance, signaling confidence in achieving positive operating cash flow in the second half of the year, though it is now tracking towards the lower end of the $0 to $15 million guided range.

Key Decisions for Investors

• Investors should monitor the company's ability to execute on its software-centric strategy, particularly the market adoption of new products like PowerTrack EMS, as this is critical to validating the pivot and sustaining margin expansion.
• The successful debt exchange has materially de-risked the balance sheet, a significant positive development that should be factored into valuation models, although the high volatility (beta of 1.32) warrants careful position sizing.
• Closely watch the company's cash flow in the second half of 2025; achieving the reaffirmed guidance for positive operating cash flow is a crucial validation point for management's operational control and financial stability.
• While management is tracking to the high end of most guidance metrics, the lowered expectation for operating cash flow requires scrutiny, and any further deterioration could pressure the stock despite the positive earnings report.